Milestone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cardiovascular medicines. Its approved product, CARDAMYST (etripamil) nasal spray, received FDA approval on December 12, 2025, as the first self-administered treatment for acute episodes of PSVT (paroxysmal supraventricular tachycardia) in adults. The company is also developing etripamil for atrial fibrillation with rapid ventricular rate (AFib-RVR) and pursuing regulatory approvals in the EU and China through partnerships.
expected 2026-11-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-20 | 2025-12-31 | 0001104659-26-032415 | EDGAR | 83K words |
| 2025-03-13 | 2024-12-31 | 0001558370-25-002849 | EDGAR | 82K words |
| 2024-03-21 | 2023-12-31 | 0001558370-24-003666 | EDGAR | 86K words |
| 2023-03-29 | 2022-12-31 | 0001558370-23-004871 | EDGAR | 80K words |
| 2022-03-24 | 2021-12-31 | 0001558370-22-004205 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001558370-21-003631 | EDGAR | — |
| 2020-03-06 | 2019-12-31 | 0001558370-20-002106 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001104659-26-094435 | EDGAR | 28K words |
| 2025-11-12 | 2025-09-30 | 0001104659-25-109689 | EDGAR | 28K words |
| 2025-08-12 | 2025-06-30 | 0001558370-25-011141 | EDGAR | 27K words |
| 2025-05-14 | 2025-03-31 | 0001558370-25-007648 | EDGAR | 22K words |
| 2024-11-12 | 2024-09-30 | 0001558370-24-015147 | EDGAR | 22K words |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011603 | EDGAR | 22K words |
| 2024-05-13 | 2024-03-31 | 0001558370-24-007860 | EDGAR | 19K words |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018665 | EDGAR | 21K words |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014399 | EDGAR | 20K words |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009254 | EDGAR | 19K words |
| 2022-11-10 | 2022-09-30 | 0001558370-22-017283 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0001558370-22-013074 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-03 | 0001104659-26-105052 | EDGAR | 2K words |
| 2026-08-12 | 0001104659-26-094466 | EDGAR | 4K words |
| 2026-03-20 | 0001104659-26-032427 | EDGAR | 4K words |
| 2026-01-26 | 0001104659-26-006483 | EDGAR | 2K words |
| 2026-01-13 | 0001104659-26-003038 | EDGAR | 1K words |
| 2026-01-06 | 0001104659-26-001099 | EDGAR | 1K words |
| 2025-12-15 | 0001104659-25-120904 | EDGAR | 3K words |
| 2025-11-12 | 0001104659-25-109744 | EDGAR | 3K words |
| 2025-08-12 | 0001104659-25-076468 | EDGAR | 3K words |
| 2025-07-14 | 0001104659-25-067579 | EDGAR | 1K words |
127 total filings indexed. 98 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001408443 |
| Ticker | MIST |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | A8 |
| Website | https://www.milestonepharma.com |
| Listed | 2019-05-09 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MIST (~200 tokens, structured JSON with cryptographic provenance)